Iradimed (IRMD) Profit After Tax (2013 - 2026)

Iradimed (IRMD) has 14 years of Profit After Tax data on file, last reported at $5.8 million in Q1 2026.

• Profit After Tax for Q1 2026 came in at $5.8 million, up 24.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.6 million (up 19.34% YoY), and the FY2025 annual result was $22.5 million, up 16.88% from the prior year.
• Profit After Tax retreated to $5.8 million in Q1 2026 per IRMD's latest filing, from $6.4 million in the prior quarter.
• Over five years, Profit After Tax peaked at $6.4 million in Q4 2025 and troughed at $2.5 million in Q1 2022.
• A 5-year average of $4.6 million and a median of $4.7 million in 2025 frame the typical range for Profit After Tax.
• On a YoY basis, Profit After Tax climbed as much as 120.53% in 2022 and fell as far as 5.63% in 2022.
• A 5-year view of Profit After Tax shows it stood at $3.7 million in 2022, then increased by 23.58% to $4.5 million in 2023, then grew by 13.37% to $5.1 million in 2024, then increased by 25.17% to $6.4 million in 2025, then slipped by 9.69% to $5.8 million in 2026.
• Business Quant data shows IRMD's Profit After Tax at $5.8 million in Q1 2026, $6.4 million in Q4 2025, and $5.6 million in Q3 2025.